 MALVERN, Pa., May 02, 2022 GLOBE NEWSWIRE -- Ocugen, Inc. NASDAQ: OCGN, a biotechnology company focused on discovering, developing and commercializing novel gene therapies, biologicals and vaccines, today announced that it will host a conference call to provide a business update and discuss its first quarter 2022 financial results at 8:30 a.m. ET on Friday, May 6, 2022. 